Jun Wan Shin

722 total citations
14 papers, 487 citations indexed

About

Jun Wan Shin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jun Wan Shin has authored 14 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jun Wan Shin's work include Genetic Neurodegenerative Diseases (10 papers), CRISPR and Genetic Engineering (6 papers) and Mitochondrial Function and Pathology (6 papers). Jun Wan Shin is often cited by papers focused on Genetic Neurodegenerative Diseases (10 papers), CRISPR and Genetic Engineering (6 papers) and Mitochondrial Function and Pathology (6 papers). Jun Wan Shin collaborates with scholars based in United States, South Korea and Germany. Jun Wan Shin's co-authors include Jong‐Min Lee, James F. Gusella, Kyung‐Hee Kim, Tammy Gillis, Marcy E. MacDonald, Michael J. Chao, Ranjit Singh Atwal, Su‐Jung Kim, Young‐Joon Surh and Hye‐Kyung Na and has published in prestigious journals such as PLoS ONE, Scientific Reports and The American Journal of Human Genetics.

In The Last Decade

Jun Wan Shin

13 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Wan Shin United States 9 391 196 52 46 35 14 487
Kamatham Pushpa Tryphena India 16 317 0.8× 81 0.4× 30 0.6× 166 3.6× 13 0.4× 21 548
Petra Bergström Sweden 11 405 1.0× 89 0.5× 21 0.4× 77 1.7× 11 0.3× 19 607
Shao‐Ming Wang Taiwan 16 351 0.9× 70 0.4× 35 0.7× 42 0.9× 5 0.1× 27 620
Nidhi Saini India 10 179 0.5× 66 0.3× 19 0.4× 44 1.0× 6 0.2× 22 382
Aram Shin United States 8 211 0.5× 119 0.6× 17 0.3× 48 1.0× 3 0.1× 19 324
Ivi Juliana Bristot Brazil 11 212 0.5× 47 0.2× 10 0.2× 37 0.8× 37 1.1× 15 440
Hye Guk Ryu South Korea 13 248 0.6× 39 0.2× 32 0.6× 13 0.3× 6 0.2× 24 395
Ribhav Mishra India 14 351 0.9× 83 0.4× 58 1.1× 32 0.7× 2 0.1× 21 470
Floriana Licitra France 3 276 0.7× 150 0.8× 16 0.3× 73 1.6× 4 0.1× 3 422
Ankita Sarkar India 14 254 0.6× 78 0.4× 13 0.3× 25 0.5× 4 0.1× 27 478

Countries citing papers authored by Jun Wan Shin

Since Specialization
Citations

This map shows the geographic impact of Jun Wan Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Wan Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Wan Shin more than expected).

Fields of papers citing papers by Jun Wan Shin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Wan Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Wan Shin. The network helps show where Jun Wan Shin may publish in the future.

Co-authorship network of co-authors of Jun Wan Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Wan Shin. A scholar is included among the top collaborators of Jun Wan Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Wan Shin. Jun Wan Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Weisburd, Ben, Kevin Correia, Jun Wan Shin, et al.. (2025). Significant underascertainment in Huntington’s disease. Brain Communications. 7(3). fcaf194–fcaf194.
4.
Shin, Jun Wan, Eun Pyo Hong, Ihn Sik Seong, et al.. (2022). Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9. JCI Insight. 7(19). 17 indexed citations
5.
Shin, Jun Wan, et al.. (2022). PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington’s disease. Molecular Therapy — Methods & Clinical Development. 26. 547–561. 8 indexed citations
6.
Shin, Jun Wan, et al.. (2022). Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease. Molecular Therapy — Methods & Clinical Development. 25. 84–95. 8 indexed citations
7.
Shin, Jun Wan, Kyung‐Soo Chun, Do‐Hee Kim, et al.. (2020). Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification. Biochemical Pharmacology. 173. 113820–113820. 133 indexed citations
8.
Kim, Kyung‐Hee, Eun Pyo Hong, Jun Wan Shin, et al.. (2020). Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects. The American Journal of Human Genetics. 107(1). 96–110. 46 indexed citations
9.
Kim, Kyung‐Hee, Kawther Abu Elneel, Jun Wan Shin, et al.. (2019). Full sequence of mutant huntingtin 3′-untranslated region and modulation of its gene regulatory activity by endogenous microRNA. Journal of Human Genetics. 64(10). 995–1004. 7 indexed citations
10.
Park, Jin Myung, Hyun-Jung Park, Jun Wan Shin, et al.. (2017). Endogenous ω-3 Fatty Acid Production by fat-1 Transgene and Topically Applied Docosahexaenoic Acid Protect against UVB-induced Mouse Skin Carcinogenesis. Scientific Reports. 7(1). 11658–11658. 18 indexed citations
11.
Shin, Aram, Jun Wan Shin, Kyung‐Hee Kim, et al.. (2017). Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels. Human Molecular Genetics. 26(7). 1258–1267. 14 indexed citations
12.
Shin, Jun Wan & Jong‐Min Lee. (2017). The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders. Therapeutic Advances in Neurological Disorders. 11. 475963405–475963405. 16 indexed citations
13.
Shin, Jun Wan, Kyung‐Hee Kim, Michael J. Chao, et al.. (2016). Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9. Human Molecular Genetics. 25(20). ddw286–ddw286. 202 indexed citations
14.
Morales, Liza D., et al.. (2014). Protein Tyrosine Phosphatases PTP-1B, SHP-2, and PTEN Facilitate Rb/E2F-Associated Apoptotic Signaling. PLoS ONE. 9(5). e97104–e97104. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026